Literature DB >> 7509596

Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene.

S Nadaud1, A Bonnardeaux, M Lathrop, F Soubrier.   

Abstract

Endothelium-derived relaxing factor (EDRF)/nitric oxide (NO) is synthesized from L-Arginine by the endothelial, constitutive, NO synthase. No facilitate genetic studies, we have cloned the human endothelial NO synthase gene and determined its structure. The gene is composed of 26 exons, ranging from 68 to 579 bp and spans 22 kb. We determined the transcription start point using human lung mRNA. No TATA-box was found at the expected distance from the transcription start point and several consensus sequences for transcription factors, including a shear-stress responsive element were identified in the 5'-flanking region. A highly polymorphic (CA) repeat within intron 13 was studied, allowing the precise genetic mapping of the gene to chromosome 7, within a 4 cM interval delimited by genethon markers AFM199Zd4 and AFM074Xg5.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509596     DOI: 10.1006/bbrc.1994.1146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation.

Authors:  Ruth Fricker; Christiane Hesse; Johanna Weiss; Yorki Tayrouz; Michael M Hoffmann; Kristina Unnebrink; Ulrich Mansmann; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

3.  Endothelial nitric oxide synthase gene intron 4 a/b VNTR polymorphism in children with APSGN.

Authors:  Hasan Dursun; Aytul Noyan; Selcuk Matyar; Mithat Buyukcelik; Mustafa Soran; Nurcan Cengiz; Gulsah Seydaoglu; Gulen Attila; Aysun K Bayazit; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

4.  Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.

Authors:  Tamara Djurić; Maja Zivković; Aleksandra Stanković; Sanja Mecanin; Dragan Alavantić
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 5.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity.

Authors:  S John; A Myerscough; A Marlow; A Hajeer; A Silman; W Ollier; J Worthington
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

Review 7.  Exhaled nitric oxide: a new lung function test.

Authors:  P J Barnes; S A Kharitonov
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

8.  Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region.

Authors:  R Arngrímsson; C Hayward; S Nadaud; A Baldursdóttir; J J Walker; W A Liston; R I Bjarnadóttir; D J Brock; R T Geirsson; J M Connor; F Soubrier
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

9.  Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study.

Authors:  Pascal L Kingah; Hung N Luu; Kelly A Volcik; Alanna C Morrison; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

10.  Novel functional role of CA repeats and hnRNP L in RNA stability.

Authors:  Jingyi Hui; Gregor Reither; Albrecht Bindereif
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.